• 제목/요약/키워드: bone metastases

검색결과 153건 처리시간 0.028초

임상가를 위한 특집 3 - rhBMP-2와 LFA-collagen scaffold를 이용한 BRONJ의 성공적인 치료 전략 (Successful strategy of treatment used to rhBMP-2 and LFA-collagen scaffold for BRONJ)

  • 권경환
    • 대한치과의사협회지
    • /
    • 제52권4호
    • /
    • pp.218-233
    • /
    • 2014
  • Bispbosphonates are a class of pharmaceutic agents, which induce apoptosis of osteoclast as well as impair osteoclastic activity to suppress bone resorption. Thus, bisphophonates are effectively used to treat osteoporosis, multiple myeloma and to prevent bone metastases of malignant cancer. However, recently dental disease have been reported associated with Bisphosphonates. Thus, there are a number of discussions about proper prevention and treatment of bisphosphonate-related osteonecrosis of jaw(BRONJ). Marshall R. Urist in 1965 made the seminal discovery that a specific protein, BMP(bone morphogenetic protein), found in the extracellular matrix of demineralized bone could induce bone formation newly when implanted in extraosseous tissues in a host. BMPs are multi-functional growth factors which are members of the transforming growth factor-beta super family and their ability is that plays a pivotal roll in inducing bone. About 18 BMP family members have been identified and characterized. Among of them, BMP-2 and BMP-7 have significant importance in bone development. In this study, patients of BRONJ were recieved who visited Department of oral and maxillofacial surgery, school of dentistry, Wonkwang university for past 3 years from 2011 to 2013. We focused on the results of the surgical intervention. We suggest that new strategy of treatment used to rhBMP-2 and LFA(Lidocaine-Fibrinogen-Aprotinin)-collagen scaffold for patients of BRONJ. The purpose of this paper is to give a brief overview of BMPs and to critically review the clinical data currently available on rhBMP-2 and LFA collage scaffold.

편도 편평세포암종의 뇌전이 1례 (A Case of Metastatic Brain Cancer from Squamous Cell Carcinoma of the Tonsil)

  • 주형로
    • 대한두경부종양학회지
    • /
    • 제15권2호
    • /
    • pp.232-234
    • /
    • 1999
  • 두경부 영역에서 발생하는 악성종양은 원격전이가 흔하지 않으나 최근 들어 국소전이에 대한 치료효과가 향상됨에 따라 원격전이가 재발과 사망의 주된 원인이 되고 있다. 원격전이중 뇌전이는 빈도는 적으나 이환시 높은 사망률을 보이므로 뇌전이를 의심하는 증상이 있을 때는 조기발견을 위한 적극적인 진단적 접근과 이에 대한 적절한 치료가 중요하다. 본 증례와 같이 고식적 수술후 국소전이에 대한 조절이 잘 되고 있는 환자에서 지속적인 두통 및 체중감소 등의 증상이 나타나는 경우 뇌전이를 의심하여 적절한 진단 방법을 통한 조기 진단과 치료가 중요하다고 생각된다.

  • PDF

시츄견에서 경부 림프절로 전이된 편도 편평세포암종 (Cervical Lymph Node Metastases of Tonsillar Squamous Cell Carcinoma in a Shih-tzu)

  • 정동인;이경우;박기태;왕지환;연성찬;이효종;이희천
    • 한국임상수의학회지
    • /
    • 제28권1호
    • /
    • pp.154-158
    • /
    • 2011
  • A 8-year-old female Shih-tzu dog (weighting 4.5 kg) with history of both hindlimb lameness and cervical mass was presented to Veterinary Teaching Hospital, Gyeongsang National University. In physical examination, ataxia, kyphosis, back pain and cervical mass were identified. Marked periosteal new bone formation of the fourth lumbar vertebra and soft tissue opacity mass of cervical region were observed in survey radiographs. Transverse computed tomography (CT) scan obtained at the lumbar and cervical lesions shown a well defined multilobulated bony mass and partially destructive lytic lesions the fourth lumbar vertebral body and a enlarged retropharyngeal lymph node with heterogeneous contrast enhancement and moderately enhancing left tonsillar mass. Neoplastic squamous epithelium which have developed vessel and lymphocyte infiltration in surrounding tissue were confirmed based on histopathologic examination. Based on the diagnostic findings the dog was diagnosed as a cervical lymph node metastases of tonsillar squamous cell carcinoma.

Whole Brain Radiotherapy Plus Chemotherapy in the Treatment of Brain Metastases from Lung Cancer: A Meta-analysis of 19 Randomized Controlled Trails

  • Liu, Wen-Jing;Zeng, Xian-Tao;Qin, Hai-Feng;Gao, Hong-Jun;Bi, Wei-Jing;Liu, Xiao-Qing
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권7호
    • /
    • pp.3253-3258
    • /
    • 2012
  • Objective: To evaluate the efficacy and safety of whole brain radiotherapy (WBRT) plus chemotherapy versus WBRT alone for treating brain metastases (BM) from lung cancer by performing a meta-analysis based on randomized controlled trials (RCTs). Methods: The PubMed, Embase, CENTRAL, ASCO, ESMO, CBM, CNKI, and VIP databases were searched for relevant RCTs performed between January 2000 and March 2012. After quality assessment and data extraction, the meta-analysis was performed using the RevMan 5.1 software, with funnel plot evaluation of publication bias. Results: 19 RCTs involving 1,343 patients were included. The meta-analyses demonstrated that compared to WBRT alone, WBRT plus chemotherapy was more effective with regard to the objective response rate (OR = 2.30, 95% CI = 1.79 - 2.98; P < 0.001); however, the incidences of gastrointestinal reactions (RR = 3.82, 95% CI = 2.33 - 6.28, P <0.001), bone marrow suppression (RR = 5.49, 95% CI = 3.65 - 8.25, P < 0.001), thrombocytopenia (RR = 5.83, 95% CI = 0.39 - 86.59; P = 0.20), leukopenia (RR = 3.13, 95% CI = 1.77 - 5.51; P < 0.001), and neutropenia (RR = 2.75, 95% CI = 1.61 - 4.68; P < 0.001) in patients treated with WBRT plus chemotherapy were higher than with WBRT alone. There was no obvious publication bias detected. Conclusion: WBRT plus chemotherapy can obviously improve total efficacy rate, butalso increases the incidence of adverse reactions compared to WBRT alone. From the limitations of this study, more large-scale, high-quality RCTs are suggested for further verification.

골스캔에서 우연히 발견된 간혈관종 (Incidental Visualization of Hepatic Hemangioma by Tc-99m-HDP Bone Scan)

  • 정용안;오주현;김정호;유이령;김성훈;손형선;정수교
    • 대한핵의학회지
    • /
    • 제39권4호
    • /
    • pp.266-267
    • /
    • 2005
  • Hepatic hemangioma is the most common benign liver tumor and must be considered in the differential diagnosis of other space occupying hepatic masses. A 54-year-old man was referred to evaluate bone metastases of lung adenocarcinoma. In our case, we thought that a focal hepatic uptake in the bore scan was a metastatic lesion, because of underlying lung adenocarcinoma. However, the findings of abdominal CT and Tc-99m RBC scan results were deemed to be characteristic of hepatic hemangioma. The biopsy of the lesion was not performed.

비소세포 폐암의 병기에 있어 통상적인 골 스캔의 역할 (The Role of Bone Scans in Routine Preoperative Evaluations of Non-Small Cell Lung Cancer Patients.)

  • 김영태;홍장미;이재익;이정상;성숙환;김주현
    • Journal of Chest Surgery
    • /
    • 제35권9호
    • /
    • pp.659-663
    • /
    • 2002
  • 이 논문은 비소세포폐암으로 새로이 진단 받은 환자에서 수술 전 병기판정에 통상적으로 골 스캔의 유용성에 대하여 연구하였다. 대상 및 방법: 서울대병원에서 2000년 1월부터 12월까지 비소세포 폐암으로 진단 받은 환자 258명을 대상으로 하였다. 수술 전 병기는 과반수에서(132명) 수술이 불가능할 정도로 진행된 상태였다. 골 원격전이의 임상 평가 항목으로 증상, alkaline phosphatase, calcium 등을 채택하였고 모든 환자의 골 스캔 결과를 검토하여, 각각의 민감도, 특이도, 음성 예측률, 양성 예측률을 산출하였다. 최종적인 골 전이의 판단은 일반 X-lay나 MRI 또는 골 생검을 기준으로 하였다. 골 전이만 없다면 수술이 가능한 (“potentially operable”)환자 126명의 임상 경과를 따로 분석하여 수술 대상 환자에서 골 전이에 대한 임상 평가의 중요성을 검토하였다. 결과: 골 전이에 대한 골 스캔의 민감도는 96%, 특이도는 75% 양성 예측률은 44%, 음성 예측률은 99%였고, 골 스캔에 대한 임상 평가의 민감도, 특이도, 양성 예측률, 음성 예측률은 각각 54%, 73%, 54%, 72%였다. 골 전이에 대한 임상 평가의 경우는 80%, 70%, 38%, 94%였다. 골 전이만 배제하면 수술이 가능하였던 “potentially operable”군 환자 126명에서 골 전이에 대한 임상 평가의 음성 예측률은 99%였다. 결론: 폐암 진단 당시 병기 결정에 있어서, 골 전이에 대한 철저한 임상 평가가 필수적이다. 특히 골 전이 외에 다른 수술 불가능 요인이 없는 환자군에서 임상 평가 결과 특이사항이 없을 경우 골 전이의 확률이 매우 낮아, 통상적인 골 스캔 없이도 근치적 수술을 고려할 수 있음을 확인하였다. 그러나 임상 평가 결과 양성인 경우에는 약 30% 이상의 환자에서 골 전이가 발견되므로 골 전이를 발견하기 위한 골 스캔은 물론 다른 여러 가지 진단법을 적극적으로 검토해야 한다.

Diagnostic Value of 18F-FDG PET/CT in Comparison to Bone Scintigraphy, CT and 18F-FDG PET for the Detection of Bone Metastasis

  • Liu, Ning-Bo;Zhu, Lei;Li, Ming-Huan;Sun, Xiao-Rong;Hu, Man;Huo, Zong-Wei;Xu, Wen-Gui;Yu, Jin-Ming
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권6호
    • /
    • pp.3647-3652
    • /
    • 2013
  • Purpose: To evaluate the diagnostic value of $^{18}F$-FDG PET/CT for detection of bone metastasis in comparison with the efficacies of $^{18}F$-FDG PET/CT, CT, $^{18}F$-FDG PET and conventional planar bone scintigraphy in a series of cancer patients. Methods: Five hundred and thirty patients who underwent both $^{18}F$-FDG PET/CT and bone scintigraphy within 1 month were retrospectively analyzed. The skeletal system was classified into 10 anatomic segments and interpreted blindly and separately. For each modality, the sensitivity, specificity, accuracy, PPV and NPV were calculated and the results were statistically analyzed. Results: Bone metastases were confirmed in 117 patients with 459 positive segments. On patient-based analysis, the sensitivity, specificity, accuracy, PPV and NPV of $^{18}F$-FDG PET/CT were significantly higher than bone scintigraphy, CT and $^{18}F$-FDG PET (P<0.05). On segment-based analysis, the sensitivity of CT, bone scintigraphy, $^{18}F$-FDG PET and $^{18}F$-FDG PET/CT were 70.4%, 89.5%, 89.1% and 97.8%, respectively (P<0.05, compared with $^{18}F$-FDG PET/CT). The overall specificity and accuracy of the four modalities were 89.1%, 91.8%, 90.3%, 98.2% and 90.3%, 90.9%, 89.8%, 98.0%, respectively (P<0.05, compared with $^{18}F$-FDG PET/CT). The PPV and NPV were 89.8%, 87.6%, 85.6%, 97.2% and 85.6%, 93.2%, 92.8%, 98.6%, respectively. Three hundred and twelve lesions or segments were presented as lytic or sclerotic changes on CT images at the corresponding sites of increased $^{18}F$-FDG uptake. In lytic or mixed lesions, the sensitivity of $^{18}F$-FDG PET/CT and $^{18}F$-FDG PET were better than bone scintigraphy, while in osteoblastic lesions bone scintigraphy had a similar performance with $^{18}F$-FDG PET/CT but better than $^{18}F$-FDG PET alone. Conclusion: Our data allow the conclusion that $^{18}F$-FDG PET/CT is superior to planar bone scintigraphy, CT or $^{18}F$-FDG PET in detecting bone metastasis. $^{18}F$-FDG PET/CT may enhance our diagnosis of tumor bone metastasis and provide more information for cancer treatment.

골전이로 인한 장골의 병적 골절의 수술적 치료 (Surgical Treatment of Pathologic Fracture of the Long Bone due to Metastatic Tumor)

  • 신규호;김동수;한수봉;한대용
    • 대한골관절종양학회지
    • /
    • 제1권1호
    • /
    • pp.52-59
    • /
    • 1995
  • Metastatic cancer is the most common tumor of the skeleton. The prevalence of pathologic fracture may increase as patient survival is prolonged by improved cancer therapy. With recent advances in orthopaedic procedure and medical management of terminal cancer patients, it is generally agreed that aggressive treatment should be undertaken for patient with pathologic fracture secondary to metastatic disease, and a team approach should be utilized. The authors have reviewed twenty cases of pathologic fracture of the long bone due to metastatic tumor treated in the Department of Orthopedic Surgery, Yonsei University College of Medicine, from April 1989 to April 1994 and the following results were obtained. 1. The mean age at surgery was 58.4 years (ranged from 24years to 86years) and among 20 cases, 10 cases were male and the others were female. 2. The most frequent site of pathologic fracture in long bone is femur(15 cases, 75%), and followed by humerus(4 cases, 20%), tibia(1 case). 3. The frequently encountered primary tumors that metastases to long bone are those of the lung(7 cases, 35%), breast(4 cases, 20%), and prostate(2 cases, 10%). 4. The operative procedure was performed by resection of the tumor mass extensively, and we used polymethylmetacrylate for filling the dead space after resection, in all cases. 5. The mean survival period after operation is 9.2 months(ranged from 1 month to 4 years and 9 month). 6. The results of postoperative pain relief status were graded as fair to excellent in 17 cases(85%).

  • PDF

비스포스포네이트 관련 악골괴사의 진단 및 치료에 대한 임상적 연구 (Clinical study of diagnosis and treatment of bisphosphonate-related osteonecrosis of the jaws)

  • 김경욱;김범진;이충현
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제37권1호
    • /
    • pp.54-61
    • /
    • 2011
  • Introduction: Bisphosphonates is used widely for the treatment of the Paget's disease, multiple myeloma, bone metastases of malignant tumors with the prevention of pain and their pathological fracture. However, it was recently suggested that bisphosphonates related osteonecrosis of the jaw (BRONJ) is a side effect of bisphosphonate use. Materials and Methods: Twenty-four individuals, who were referred to the Department of Oral and Maxillofacial surgery, Dankook University Dental Hospital, were selected from those who had exposed bone associated with bisphosphonates from January, 2005 to December, 2009 according to the criteria of American Association of Oral and Maxillofacial Surgeons (AAOMS) for BRONJ. The patients group consisted of 7 males and 17 females between the age of 46 to 78 years (average 61.8 years). Each patient had panoramic imaging, computed tomography (CT), whole body bone scanning performed for a diagnosis and biopsy sampling from the necrotizing tissue. C-terminal cross-linking telopeptide of type I collagen (CTX) level of patients who had undergone surgical intervention was measured 7 days before surgery. Results: The main cause of bone exposure was post-extraction (15), chronic periodontitis (4), persistent irritation of the denture (3). Twenty people had undergone BRONJ treatment for two to eight months except for 4 people who had to maintain the bisphosphonates treatment to prevent a metastasis and bone trabecular pain with medical treatment. When the bisphosphonate treatment was suspended at least for 3 months and followed up according to the AAOMS protocols, the exposed necrotizing bones were found to be covered by soft tissue. Conclusion: Prevention therapy, interruption of bisphophonates for at least 3 months and cooperation with the physician for conservative treatment are the essential for treating BRONJ patient with high risk factors. The CTX level of BRONJ patients should be checked before undergoing surgical intervention. Surgical treatments should be delayed in the case of a CTX level <150 pg/mL.

골육종에서 Maspin 발현의 임상적 의의 (Clinical Significance of Maspin Expression in Osteosarcoma)

  • 최재림;한일규;이미라;조환성;오주한;김한수
    • 대한골관절종양학회지
    • /
    • 제15권1호
    • /
    • pp.26-33
    • /
    • 2009
  • 목적: 골육종에서 maspin의 발현 정도를 살펴보고 골육종 임상 경과와의 연관성을 고찰해 본다. 대상 및 방법: 39 예의 골육종 조직에서 maspin 의 발현 정도를 RT-PCR 기법을 이용해 관찰하였으며, 골조직의 항암 화학요법에 대한 반응, 절제 후 국소 재발, 원격전이 등과 같은 임상적 지표와의 연관성을 통계적으로 분석하였다 결과: 저자가 정한 maspin 고 발현군에서는 저 발현군에 비해 항암 화학요법의 반응도가 높고 원격 전이와 국소 재발도 유의성 있게 적은 것으로 나타났다. 원격 전이도 maspin 고발현군과 항암 화학요법 반응도가 높은 군에서 유의하게 낮게 동반되었다. 그리고 5년 metastasis-free survival이 maspin 저 발현군($25.4{\pm}13.0%$) 보다 고 발현군($69.0{\pm}10.5%$)에서 유의성 있게 높았다(p=0.006). 결론: 골육종에서 maspin 유전자의 발현은 종양세포의 항암 화학요법 반응도 및 원격 전이, 5년 metastasis-free survival에 유의한 연관성을 보이고 있어 골육종의 예후를 예견할 수 있는 중요한 지표가 될 수 있을 것으로 생각된다.

  • PDF